Repaglinide Tablet
Product Images NDC 33342-249

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 33342-249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

505 (Repaglinide Figure 1)

A line graph depicting the change in HbA1c (%) over 24 treatment weeks. The graph compares three groups: Repaglinide plus Pioglitazone combination, Repaglinide alone, and Pioglitazone alone, showing the percentage change in HbA1c on the vertical axis and treatment weeks on the horizontal axis.*

FDA Label Image

Str (Repaglinide Str)

Chemical structure of Repaglinide, showing its molecular composition including carbon rings, functional groups like carboxylic acid and amide, and alkyl side chains, depicted in a structural diagram format.*

FDA Label Image

505 (Repaglinide Tablets 0 5mg 1000s)

Packaging label for Repaglinide Tablets, USP 0.5 mg, supplied in a bottle of 1000 tablets. The label indicates storage instructions between 20° to 25°C, warnings for moisture protection, and child-resistant closure. The product is manufactured by Macleods Pharmaceuticals Ltd. in India and labeled for Macleods Pharma USA, Inc., Princeton, NJ.*

FDA Label Image

505 (Repaglinide Tablets 0 5mg 100s)

Repaglinide Tablets, USP 0.5 mg oral tablets label by Macleods Pharmaceuticals Limited. The label shows 100 tablets, includes storage instructions, manufacturer and distributor details, and a highlighted strength of 0.5 mg. It also includes barcodes and dosage directions to refer to package insert for full information.*

FDA Label Image

505 (Repaglinide Tablets 1 mg 1000s)

Repaglinide Tablets, USP 1 mg oral tablets packaging label by Macleods Pharmaceuticals Limited. The label indicates 1 mg strength, 1000 tablets per bottle, with storage instructions (20° to 25°C), and advises keeping bottles tightly closed and protected from moisture. Manufactured for Macleods Pharma USA, Inc. and produced at Oxalis Labs, India.*

FDA Label Image

505 (Repaglinide Tablets 1 mg 100s)

Repaglinide Tablets USP 1 mg oral tablets label from Macleods Pharmaceuticals Limited. The label indicates that each tablet contains 1 mg Repaglinide, with a count of 100 tablets per container. It includes storage instructions and proprietary information for Macleods Pharma USA, Inc., Princeton, NJ, and manufacturing details for Macleods Pharmaceuticals Ltd. at Oxalis Labs, India.*

FDA Label Image

505 (Repaglinide Tablets 2 mg 1000s)

Label for Repaglinide Tablets, USP 2 mg oral tablets, packaged in a bottle with 1000 tablets. Label indicates storage instructions, manufacturer Macleods Pharmaceuticals Ltd at Oxalis Labs in Baddi, India, and the labeler Macleods Pharma USA, Inc., Princeton, NJ. Includes dosage strength prominently and barcode details.*

FDA Label Image

505 (Repaglinide Tablets 2 mg 100s)

Repaglinide Tablets USP 2 mg oral tablets packaging label. The label indicates a package size of 100 tablets and includes storage instructions, manufacturer information for Macleods Pharmaceuticals Ltd. at Oxalis Labs in India, and distribution by Macleods Pharma USA, Inc. Barcodes and regulatory text are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.